age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
79.33698
|
female
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 24,248
| 16,439.4375
| 15,007.7578
| 16
|
white
| 28.699219
| 43
| 0.625
| 0.439941
| 1
| 1
| 0
|
no
| 0.05
| 0.02
|
no dnr
| 21
| 64
| 12.798828
| 77
| 28
| 36.5
| 174.28125
| 3.299805
| 0.299988
| 1.299805
| 138
| 7.429688
| 264
| 30
| 2,110
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 109
| 1
|
49.96597
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 0
|
under $11k
| 26
| 14,104
| 9,735.3125
| 9,969.23438
| 23.5
|
white
| 30
| 32
| 0.684937
| 0.591919
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 11
| 106
| 3.699707
| 79
| 28
| 38.09375
| 247.59375
| 4.199219
| 0.5
| 1
| 134
| 7.419922
| 92
| 4
| 4,425
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 261
| 1
|
78.22296
|
male
| 1
| 25
|
Coma
|
Coma
| 2
| null | null | 44
| 59,397
| 39,876.875
| 41,626.9062
| 31.25
|
white
| 35.296875
| 54
| 0.033997
| 0.015999
| 9
| 0
| 1
|
no
| null | null |
dnr after sadm
| 20
| 118
| 13.798828
| 69
| 40
| 37.89844
| 82.84375
| null | 0.699951
| 0.799927
| 140
| 7.379883
| 262
| 37
| null | null | null |
<2 mo. follow-up
| 4.991211
| 25
| 1
|
64.18896
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 4
| 12
|
$11-$25k
| 0
| 10,001
| 6,335.3242
| 6,368.84766
| 14
|
white
| 18.597656
| 12
| 0.67688
| 0.379944
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.95
|
no dnr
| 9
| 105
| 31.5
| 70
| 22
| 36.29688
| 261.1875
| null | 0.899902
| 2.899902
| 136
| 7.459961
| 184
| 69
| 1,860
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 676
| 0
|
73.73297
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 0
| 13,660
| 9,851.0547
| 8,176.41797
| 28
|
white
| 36.195313
| 69
| 0.504883
| 0.387939
| 1
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 12
| 112
| null | 69
| 24
| 35.79688
| null | null | null | 1.599854
| 138
| null | 75
| 38
| 2,600
| 6
| 2
|
SIP>=30
| 2
| 675
| 0
|
58.47198
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 16,624
| 10,855.6016
| 11,437.0078
| 9.5
|
white
| 15.398438
| 6
| 0.75293
| 0.494995
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 13
| 83
| 20.597656
| 67
| 20
| 35.39844
| null | 4.199219
| 0.399963
| 1.5
| 140
| null | 126
| 27
| 1,400
| 2
| 3
|
adl>=4 (>=5 if sur)
| 3
| 80
| 1
|
65.659
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 8
|
under $11k
| 0
| 3,161
| 2,090.9981
| 2,328.34961
| 5
|
white
| 12.199219
| 18
| 0.790894
| 0.559937
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
dnr after sadm
| 1
| 115
| 17.296875
| 115
| 10
| 38.5
| 320
| null | null | 0.799927
| 134
| 7.509766
| 155
| 12
| 1,500
| 5
| 5
| null | 5
| 224
| 1
|
57.65598
|
male
| 0
| 19
|
Lung Cancer
|
Cancer
| 2
| 10
| null | 0
| 26,969
| 18,235.4688
| 19,058.5156
| 3.333332
|
white
| 19.097656
| 14
| 0.682983
| 0.388977
| 1
| 0
| 0
|
metastatic
| 1
| 0.51
|
no dnr
| 19
| 72
| 5.699219
| 101
| 30
| 38.59375
| null | 3.799805
| 0.599976
| 0.899902
| 131
| null | 179
| 12
| null | 0
| 0
|
SIP>=30
| 0
| 120
| 1
|
65.90796
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 2,496
| 1,644.8779
| 1,368.30957
| 10
|
white
| 19.398438
| 40
| 0.86499
| 0.776978
| 1
| 1
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 5
| 61
| 6.099609
| 51
| 32
| 35.59375
| 485.6875
| null | null | 1.299805
| 132
| 7.449219
| 96
| 64
| 2,200
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 406
| 1
|
52.87097
|
male
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
| null | 0
| 36,129
| 25,131.2344
| 28,057.5469
| 21.333328
|
white
| 21.296875
| 35
| 0.712891
| 0.625977
| 6
| 0
| 0
|
yes
| 0.25
| 0.05
|
no dnr
| 19
| 99
| 10.199219
| 81
| 22
| 36.09375
| 247.59375
| null | 0.199982
| 1.299805
| 134
| 7.429688
| 83
| 23
| null | null | 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
72.77496
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 9
| null | 0
| 5,221
| 3,341.7441
| 3,229.06836
| 5.5
|
white
| 16.097656
| 30
| 0.878906
| 0.79895
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 7
| 73
| 10.298828
| 60
| 24
| 35.59375
| 244
| 3.399902
| 0.899902
| 1.099854
| 134
| 7.519531
| 130
| 15
| 2,450
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 548
| 1
|
57.44299
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 7,868
| 5,170.9336
| 5,612.03906
| 20
|
white
| 31
| 35
| 0.760986
| 0.620972
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 6
| 103
| 6.299805
| 65
| 32
| 35.89844
| 276.1875
| 3.099609
| 0.299988
| 1.299805
| 141
| 7.40918
| 101
| 32
| 1,925
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 668
| 0
|
59.20599
|
male
| 1
| 7
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 61
| 17,033
| 12,977.8281
| 14,498.8125
| 18
|
white
| 24.898438
| 40
| 0.440979
| 0.366943
| 1
| 0
| 0
|
no
| 0.3
| 0.25
|
dnr after sadm
| 6
| 70
| 11.898438
| 130
| 40
| 38
| 86.65625
| 3.899902
| 0.699951
| 1
| 143
| 7.40918
| 181
| 27
| 3,225
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
58.94897
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 13
|
$11-$25k
| 0
| 3,548
| 2,230.9492
| 2,404.69922
| 10
|
white
| 12.898438
| 22
| 0.918945
| 0.862915
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 5
| 49
| 18.097656
| 60
| 24
| 38.39844
| 190
| 1.299805
| 0.699951
| 0.599976
| 132
| 7.349609
| 184
| 5
| 825
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 667
| 0
|
45.53299
|
male
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 13
| null | 0
| 9,094
| 6,265.3672
| 6,837.56641
| 14
|
white
| 26.296875
| 35
| 0.776978
| 0.643921
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 10
| 101
| 12.599609
| 81
| 24
| 36.69531
| null | null | 0.399963
| 2.399902
| 134
| null | 210
| 44
| 2,250
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 664
| 0
|
67.85199
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 4,016
| 2,785.1367
| 3,827.56836
| 21
|
white
| 18.597656
| 23
| 0.832886
| 0.726929
| 1
| 0
| 0
|
yes
| 0.7
| 0.6
|
dnr after sadm
| 4
| 65
| 8
| 48
| 20
| 35.59375
| null | 4.099609
| 1.199951
| 1
| 134
| null | 104
| 8
| null | 0
| 0
|
<2 mo. follow-up
| 0
| 59
| 1
|
68.98596
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 2,823
| 1,840.5918
| 1,823.93945
| 8
|
white
| 11.599609
| 13
| 0.871948
| 0.712891
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 110
| 3.699707
| 76
| 24
| 38.19531
| null | null | null | 1.699951
| 131
| null | 245
| 25
| 1,785
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 279
| 1
|
41.64499
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$11-$25k
| 0
| 28,886
| 19,517.5781
| 20,677.8281
| 28.333328
|
white
| 23.5
| 48
| 0.87793
| 0.834961
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 20
| 65
| 14.5
| 119
| 24
| 36.19531
| 209.5
| 3.399902
| 0.599976
| 0.899902
| 138
| 7.429688
| 115
| 20
| 600
| null | 0
|
no(M2 and SIP pres)
| 0
| 661
| 0
|
71.41095
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 10,856
| 7,223.6719
| 7,333.58984
| 9
|
white
| 16.097656
| 47
| 0.875977
| 0.793945
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 2
| 62
| null | 81
| 20
| 37
| null | null | null | 0.699951
| 141
| null | 129
| 8
| 2,075
| 2
| 3
|
adl>=4 (>=5 if sur)
| 3
| 77
| 1
|
54.12997
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
under $11k
| 0
| 29,479
| 20,409.8906
| 20,370.3906
| 27
|
white
| 28.699219
| 67
| 0.760986
| 0.68396
| 2
| 1
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 13
| 108
| 8.099609
| 79
| 20
| 35.39844
| null | 3.399902
| 0.699951
| 1
| 134
| null | 111
| 19
| 3,175
| 6
| 5
|
SIP>=30
| 5
| 527
| 1
|
64.99097
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 3,960
| 2,424.6211
| 1,743.30957
| 6
|
white
| 16.796875
| 7
| 0.819946
| 0.611938
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 5
| 59
| 10.099609
| 135
| 40
| 35.69531
| null | 3.799805
| 0.799927
| 1.5
| 124
| null | 171
| 40
| 3,775
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 657
| 0
|
46.56497
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 8,909
| 6,108.7539
| 6,189.33984
| 11
|
white
| 15.199219
| 15
| 0.928955
| 0.902954
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 5
| 118
| 9.699219
| 60
| 10
| 37.79688
| 144
| 2.5
| 0.399963
| 1
| 134
| 7.5
| 126
| 11
| 2,650
| null | null | null | 2.746094
| 657
| 0
|
78.54297
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 4,668
| 2,988.3613
| 3,181.37891
| 13
|
white
| 19
| 12
| 0.758911
| 0.503906
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
dnr before sadm
| -1
| 107
| 12.099609
| 117
| 10
| 37.89844
| 217.5
| null | null | 0.899902
| 149
| 7.40918
| 164
| 51
| 2,580
| 1
| null | null | 1.166748
| 275
| 1
|
77.55798
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 7
|
$11-$25k
| 0
| 7,842
| 5,684.3164
| 5,780.52734
| 9.5
|
white
| 37.195313
| 37
| 0.452942
| 0.250977
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 79
| 8.298828
| 52
| 24
| 38.79688
| 390.4375
| null | 0.899902
| 4.299805
| 140
| 7.389648
| 110
| 67
| 1,950
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 655
| 0
|
72.06598
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| 30,235
| 19,548.6094
| 21,709.6406
| 19.666656
|
white
| 19.097656
| 26
| 0.779907
| 0.708984
| 4
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 16
| 108
| 20.898438
| 160
| 32
| 38.39844
| 287.75
| 3.299805
| 0.799927
| 0.799927
| 131
| 7.479492
| 110
| 15
| 3,950
| 1
| 0
|
SIP>=30
| 0
| 655
| 0
|
69.37994
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 9,324
| 5,800.918
| 5,449.05859
| 13
|
white
| 19.796875
| 30
| 0.635986
| 0.325989
| 1
| 0
| 0
|
metastatic
| 1
| 0.6
|
dnr after sadm
| 1
| 72
| null | 70
| 28
| 35.59375
| null | 3.799805
| 0.699951
| 8.699219
| 134
| null | 99
| 56
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
68.20294
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 46,267
| 45,581.8438
| 49,192.9375
| 49
|
white
| 23
| 41
| 0.761963
| 0.685913
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 14
| 64
| 21.5
| 36
| 32
| 37.89844
| 318
| 2.799805
| 0.899902
| 2.699707
| 132
| 7.279297
| 268
| 49
| 1,125
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
52.22699
|
male
| 1
| 20
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 8
| null | 37
| 26,657
| 18,330.8281
| 20,138.2188
| 15.666664
|
white
| 19.296875
| 22
| 0.74292
| 0.594971
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 20
| 56
| 9.199219
| 160
| 40
| 38.29688
| 218.5
| null | null | 1.399902
| 132
| 7.469727
| 149
| 13
| 1,300
| null | 5
|
<2 mo. follow-up
| 5
| 20
| 1
|
57.59097
|
male
| 0
| 27
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 61
| 39,876
| 27,313.75
| 29,164.2031
| 28.75
|
white
| 21.796875
| 27
| 0.731934
| 0.579956
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 27
| 63
| 0.399963
| 130
| 40
| 39.59375
| 182.84375
| 2.899902
| 3
| 1.399902
| 140
| 7.439453
| 395
| 31
| 5,450
| null | 0
|
SIP>=30
| 0
| 207
| 1
|
63.98898
|
male
| 1
| 5
|
Lung Cancer
|
Cancer
| 3
| null | null | 100
| 5,764
| 3,601
| 3,166.89844
| 29
|
white
| 30.296875
| 21
| 0.014999
| 0
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.2
|
dnr after sadm
| 1
| 68
| 4.599609
| 39
| 22
| 35.89844
| 466.625
| null | 0.899902
| 1.199951
| 142
| 7.529297
| 132
| 26
| 1,850
| null | null |
<2 mo. follow-up
| 4.333008
| 5
| 1
|
83.31299
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
| null | 9
| 11,919
| 8,023.8086
| 8,385.92969
| 24.5
|
white
| 22.296875
| 40
| 0.738892
| 0.656982
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 9
| 76
| 7
| 70
| 24
| 36.59375
| null | 4.599609
| 0.399963
| 1
| 137
| null | 114
| 5
| 1,975
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 648
| 0
|
76.83197
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 9
| 3,917
| 2,545.1894
| 2,199.51953
| 5
|
white
| 17.796875
| 24
| 0.831909
| 0.725952
| 1
| 0
| 1
|
no
| 0.75
| 0.75
|
dnr after sadm
| 5
| 117
| 24.5
| 58
| 10
| 38.89844
| 154.53125
| 2.599609
| 24
| 5.899414
| 141
| 7.40918
| 118
| 81
| 30
| null | 6
|
no(M2 and SIP pres)
| 6
| 647
| 0
|
67.79999
|
male
| 0
| 8
|
Coma
|
Coma
| 1
| 14
| null | 100
| 28,580
| 18,889.2812
| 19,848.125
| 32.5
|
white
| 28.5
| 38
| 0.060997
| 0.032997
| 3
| 0
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 5
| 75
| 26.796875
| 118
| 20
| 35.29688
| 309.5
| null | 0.5
| 0.699951
| 137
| 7.449219
| 150
| 14
| 1,500
| null | 6
|
<2 mo. follow-up
| 6
| 12
| 1
|
58.59799
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 20,012
| 15,636.9688
| 16,694.8594
| 15.5
|
white
| 24.398438
| 53
| 0.748901
| 0.669922
| 8
| 0
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 8
| 66
| 3.5
| 79
| 26
| 38.69531
| 128.875
| 2.199707
| 1.299805
| 0.599976
| 156
| 7.459961
| 119
| 9
| 6,200
| null | null |
<2 mo. follow-up
| 2.768555
| 19
| 1
|
78.10498
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 5
|
under $11k
| 9
| 3,989
| 2,674.8652
| 2,562.94922
| 14
|
white
| 23.597656
| 26
| 0.738892
| 0.589966
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 67
| 15.5
| 114
| 28
| 36.89844
| 112.5
| 4.099609
| 0.699951
| 3
| 132
| 7.489258
| 123
| 40
| 830
| null | null |
no(M2 and SIP pres)
| 5.21875
| 644
| 0
|
66.71899
|
female
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 40,797
| null | null | 12.666664
|
white
| 23.296875
| 35
| 0.645996
| 0.545898
| 1
| 1
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 20
| 76
| 7.399414
| 74
| 24
| 35.89844
| 222.71875
| 4
| 1.799805
| 1
| 142
| 7.319336
| 92
| 28
| 1,220
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 370
| 1
|
73.5
|
male
| 0
| 16
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 14,996
| 9,510.5469
| 9,354.44531
| 11.333328
|
white
| 6.299805
| 13
| 0.910889
| 0.793945
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.75
|
dnr after sadm
| 1
| 63
| 13.5
| 132
| 28
| 39.29688
| 123.625
| 1.899902
| 1.099854
| 0.699951
| 139
| 7.419922
| 127
| 3
| 5,375
| null | 1
|
no(M2 and SIP pres)
| 1
| 120
| 1
|
71.77295
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 10
| null | 0
| 6,705
| 4,389.4414
| 3,861.16992
| 6
|
white
| 21.597656
| 36
| 0.810913
| 0.69397
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 7
| 59
| 7.5
| 79
| 16
| 36.19531
| null | 3.899902
| 0.199982
| 1.5
| 139
| null | 134
| 23
| null | 0
| 2
|
<2 mo. follow-up
| 2
| 18
| 1
|
82.93799
|
female
| 1
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 8
|
under $11k
| 26
| 6,338
| 4,364.4844
| 4,638.00781
| 22
|
white
| 24.597656
| 63
| 0.53894
| 0.339966
| 2
| 1
| 1
|
no
| 0.5
| 0
|
dnr before sadm
| -1
| 67
| 15.199219
| 128
| 30
| 34.39844
| 260
| 2.699707
| 0.299988
| 0.899902
| 135
| 7.479492
| 240
| 23
| 1,350
| null | null |
<2 mo. follow-up
| 5.993164
| 4
| 1
|
81.63995
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
| null | 9
| 55,955
| 35,859.2188
| 40,620.4688
| 19.25
|
white
| 23.398438
| 64
| 0.670898
| 0.574951
| 6
| 0
| 0
|
no
| 0.5
| 0.125
|
dnr after sadm
| 8
| 137
| 13.599609
| 60
| 24
| 35.69531
| 369.5625
| null | null | 0.899902
| 130
| 7.319336
| 194
| 25
| 1,975
| null | 5
|
SIP>=30
| 5
| 345
| 1
|
69.60999
|
female
| 0
| 32
|
Coma
|
Coma
| 3
| 12
|
$11-$25k
| 44
| 150,249
| 106,119.312
| 113,850.062
| 28.5
|
white
| 25.398438
| 48
| 0.266968
| 0.198975
| 40
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 26
| 117
| 11.099609
| 68
| 28
| 35.59375
| 160
| 2.299805
| 3.799805
| 0.899902
| 144
| 7.329102
| 256
| 25
| 5,550
| null | 0
|
<2 mo. follow-up
| 0
| 34
| 1
|
79.995
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 7
| 9
|
$25-$50k
| 9
| 8,495
| 5,334.9688
| 4,880.17969
| 9.5
|
white
| 26.296875
| 38
| 0.628906
| 0.445984
| 1
| 0
| 1
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 102
| 3.899902
| 63
| 24
| 35.79688
| null | null | null | 0.899902
| 139
| null | 100
| 9
| null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 197
| 1
|
76.63196
|
male
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 10,375
| 6,827.0039
| 6,236.20703
| 7.333332
|
white
| 19.5
| 34
| 0.765991
| 0.628906
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 18
| 52
| 9.199219
| 118
| 24
| 35.79688
| null | null | 0.299988
| 0.899902
| 137
| null | 153
| 16
| null | null | 2
|
no(M2 and SIP pres)
| 2
| 639
| 0
|
72.61298
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 9
| 10,843
| 6,651.1914
| 4,538.21875
| 5
|
white
| 26.699219
| 16
| 0.394958
| 0.099991
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
dnr after sadm
| 3
| 117
| 23.796875
| 60
| 14
| 38.69531
| 213.3125
| 3.299805
| 0.799927
| 4.399414
| 145
| 7.369141
| 299
| 67
| 1,081
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
70.56494
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
|
$25-$50k
| 0
| 2,365
| 1,585.7607
| 1,604.69922
| 5
|
white
| 18.097656
| 20
| 0.859985
| 0.767944
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 4
| 73
| 5.399414
| 63
| 24
| 35.89844
| null | 3.099609
| 1.5
| 1.399902
| 128
| null | 218
| 30
| 4,275
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 635
| 0
|
74.70996
|
male
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 37
| 200,862
| 143,377.125
| 142,079.875
| 37.75
|
white
| 34.09375
| 46
| 0.243988
| 0.141998
| 21
| 0
| 0
|
no
| null | null |
dnr after sadm
| 35
| 51
| 9.798828
| 81
| 20
| 36.5
| 400
| 4
| 0.5
| 1.199951
| 134
| 7.459961
| 181
| 35
| 1,475
| null | 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
69.47296
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 5,038
| 3,265.9492
| 3,421.63867
| 2
|
white
| 22.097656
| 39
| 0.816895
| 0.703979
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 43
| 8.898438
| 130
| 29
| 40.19531
| 300
| 2.599609
| 0.299988
| 0.599976
| 135
| 7.399414
| 138
| 6
| 1,550
| 1
| null |
<2 mo. follow-up
| 1.166748
| 20
| 1
|
65.487
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 37
| 5,066
| 3,334.2227
| 3,096.9082
| 5
|
white
| 18.699219
| 24
| 0.793945
| 0.668945
| 1
| 0
| 0
|
no
| 0.8
| 0.512
|
dnr after sadm
| 3
| 58
| 9.699219
| 77
| 32
| 35.5
| null | null | null | 1.399902
| 136
| null | 108
| 41
| null | 0
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
67.84399
|
female
| 1
| 12
|
Coma
|
Coma
| 0
| 16
|
>$50k
| 94
| 34,959
| 24,302.5469
| 26,362.4375
| 29
|
white
| 26.699219
| 33
| 0.082993
| 0.047997
| 7
| 0
| 0
|
no
| 0.24
| 0.24
|
dnr after sadm
| 5
| 75
| 17
| 105
| 25
| 38.09375
| 285.6875
| null | null | 0.699951
| 138
| 7.429688
| 112
| 6
| 3,975
| null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
76.26794
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 26
| 8,633
| 5,600.3711
| 5,183.20703
| 14.5
|
white
| 27
| 33
| 0.494995
| 0.293945
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 102
| 3.899902
| 110
| 10
| 36.79688
| 374.25
| 2.799805
| 0.199982
| 0.5
| 139
| 7.40918
| 121
| 6
| 2,125
| null | 1
|
no(M2 and SIP pres)
| 1
| 634
| 0
|
50.86099
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 14
| null | 0
| 3,603
| 2,394.8223
| 1,887.16992
| 4.5
|
white
| 31.296875
| 21
| 0.760986
| 0.620972
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 1
| 56
| 8.5
| 106
| 10
| 38.89844
| 135
| 2.299805
| 0.699951
| 5
| 127
| 7.399414
| 96
| 55
| 472
| 1
| 0
|
SIP>=30
| 0
| 634
| 0
|
62.92398
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 100
| 58,428
| 38,707.1562
| 39,558.0312
| 47
|
white
| 44.195313
| 82
| 0.002
| 0
| 21
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 99
| 6.899414
| 126
| 18
| 36.29688
| null | 3.899902
| 0.799927
| 0.899902
| 140
| null | 116
| 14
| null | null | 1
|
<2 mo. follow-up
| 1
| 3
| 1
|
75.22198
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
| null | 0
| 46,467
| 31,250.3906
| 32,330.6406
| 27.333328
|
white
| 25.398438
| 39
| 0.681885
| 0.587891
| 9
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 15
| 121
| 8.298828
| 70
| 16
| 36.09375
| 309.5
| 4.199219
| 0.399963
| 1.399902
| 140
| 7.449219
| 194
| 22
| 3,400
| null | 0
|
no(M2 and SIP pres)
| 0
| 633
| 0
|
90.36798
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 2,206
| 1,536.5508
| 1,430.35938
| 11
|
white
| 19.597656
| 36
| 0.775879
| 0.642944
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 4
| 75
| 8.099609
| 145
| 24
| 37.79688
| 230
| null | null | 1.199951
| 128
| 7.519531
| 166
| 20
| 1,570
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 631
| 0
|
79.27698
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 6,405
| 4,273.7734
| 4,210.89844
| 7.5
|
white
| 19.097656
| 39
| 0.826904
| 0.717896
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 7
| 70
| 12.5
| 110
| 32
| 38.69531
| 125.45312
| 2.099609
| 5.5
| 1.199951
| 133
| 7.5
| 124
| 33
| 2,525
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 631
| 0
|
89.12
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 4
| null | 0
| 3,031
| 2,076.1348
| 2,175.12891
| 15
|
white
| 18.097656
| 20
| 0.803955
| 0.68396
| 1
| 1
| 1
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 57
| 16.597656
| 134
| 12
| 37.5
| 285
| 3.099609
| 0.5
| 1.699951
| 137
| 7.449219
| 126
| 34
| 775
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 248
| 1
|
74.42798
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 2
| 5
|
under $11k
| 0
| 7,917
| 5,127.7461
| 4,562.58984
| 13
|
white
| 12.599609
| 25
| 0.85498
| 0.678955
| 1
| 0
| 1
|
metastatic
| 0.05
| 0
|
no dnr
| 10
| 98
| 10.298828
| 77
| 24
| 35.69531
| 304
| null | 0.799927
| 0.899902
| 137
| 7.349609
| 334
| 17
| null | 1
| 0
| null | 0
| 102
| 1
|
63.97498
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 5,272
| 3,413.043
| 3,295.48828
| 10
|
white
| 18.199219
| 11
| 0.685913
| 0.392944
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.1
|
dnr after sadm
| 1
| 59
| 6.599609
| 113
| 11
| 36.39844
| 100
| 2.5
| 9.5
| 1.399902
| 140
| 7.569336
| 108
| 31
| 3,470
| 0
| 2
|
adl>=4 (>=5 if sur)
| 2
| 145
| 1
|
73.28998
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 9
| 44,287
| 29,971.6406
| 30,189.6562
| 29.333328
|
white
| 35.59375
| 50
| 0.390991
| 0.271973
| 7
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 2
| 68
| 8.298828
| 120
| 20
| 36.39844
| null | 4.299805
| 0.399963
| 1.5
| 138
| null | 233
| 42
| 2,025
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 628
| 0
|
21.63199
|
female
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 41
| 148,162
| 101,257.312
| 121,249.375
| 47
|
white
| 26.097656
| 38
| 0.819946
| 0.759888
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 53
| 66
| 17.199219
| 104
| 32
| 38.39844
| 165
| null | null | 1.5
| 133
| 7.479492
| 163
| 22
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 628
| 0
|
72.435
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 74,657
| 49,330.9062
| 53,275.25
| 16.75
|
white
| 30.097656
| 42
| 0.48999
| 0.371948
| 16
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 25
| 96
| 5.699219
| 69
| 16
| 36.09375
| 323.75
| 4.099609
| 0.399963
| 1.199951
| 136
| 7.459961
| 115
| 6
| 1,450
| null | 0
|
no(M2 and SIP pres)
| 0
| 627
| 0
|
70.75195
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 8
| null | 0
| 3,427
| 2,172.2734
| 1,754.34961
| 9
|
white
| 30.796875
| 44
| 0.580933
| 0.387939
| 1
| 1
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 5
| 67
| 9.5
| 80
| 24
| 39.09375
| 257.5
| 2.099609
| 0.299988
| 1.699951
| 137
| 7.40918
| 82
| 40
| 775
| 1
| 0
| null | 0
| 240
| 1
|
83.71497
|
female
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 8
| null | 0
| 35,843
| 24,067.2188
| 23,331.1875
| 28
|
white
| 22.5
| 43
| 0.563965
| 0.452942
| 7
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 15
| 62
| 18.898438
| 134
| 28
| 38.69531
| 136
| 1.699951
| 0.199982
| 0.899902
| 140
| 7.459961
| 206
| 16
| 1,325
| null | 0
|
no(M2 and SIP pres)
| 0
| 627
| 0
|
78.75696
|
male
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 8
| null | 0
| 27,466
| 18,589.9375
| 18,974.4062
| 27.5
|
white
| 26.398438
| 40
| 0.547974
| 0.43396
| 7
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 9
| 70
| 12.798828
| 78
| 24
| 35.79688
| 362.9375
| null | 0.299988
| 1.099854
| 138
| 7.429688
| 278
| 18
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 536
| 1
|
71.37897
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 3,740
| 2,478.7617
| 1,955.72949
| 9
|
white
| 16.699219
| 24
| 0.876953
| 0.794922
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 39
| 32.59375
| 130
| 10
| 36
| 152
| 3.199707
| 8.199219
| 5.199219
| 127
| 7.369141
| 212
| 105
| 75
| null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
78.77594
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 8
| null | 0
| 4,257
| 2,828.1602
| 2,308.66992
| 11
|
white
| 16.398438
| 18
| 0.675903
| 0.505981
| 1
| 1
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 1
| 74
| 4.899414
| 77
| 24
| 36.39844
| 260
| 2.199707
| 0.099991
| 0.899902
| 137
| 7.319336
| 141
| 17
| 3,210
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 557
| 1
|
48.68698
|
female
| 0
| 109
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 13
|
under $11k
| 0
| 130,793
| 86,623.625
| 98,248.9375
| 34.25
|
white
| 31.296875
| 59
| 0.657959
| 0.480957
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 27
| 129
| 12.398438
| 85
| 22
| 36.5
| null | 3.899902
| 0.599976
| 1
| 135
| null | 148
| 27
| null | null | 0
|
SIP>=30
| 0
| 623
| 0
|
74.17096
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 10,170
| 6,691.2109
| 6,019.69922
| 8
|
white
| 22.199219
| 46
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 14
| 78
| 8.298828
| 53
| 16
| 35.89844
| null | null | null | 1.399902
| 138
| null | 124
| 18
| 3,100
| 2
| 0
|
no(M2 and SIP pres)
| 0
| 625
| 0
|
56.92798
|
female
| 1
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 9
| 7,075
| 4,833.2344
| 4,892.78906
| 11
|
white
| 20.097656
| 11
| 0.626953
| 0.314941
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 4
| 117
| 9.298828
| 126
| 24
| 36.39844
| 224
| null | 0.599976
| 1.099854
| 135
| 7.449219
| 115
| 23
| 1,055
| null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
69.54095
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,304
| 4,241.2578
| 3,871.61914
| 6
|
white
| 24
| 28
| 0.649902
| 0.470947
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 9
| 82
| 0.099991
| 148
| 22
| 36.09375
| null | null | null | 1.399902
| 145
| null | 155
| 39
| null | null | 3
|
<2 mo. follow-up
| 3
| 20
| 1
|
74.93994
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 9
| 48,671
| 31,515.9844
| 33,310.1562
| 24.5
|
white
| 25.398438
| 35
| 0.647949
| 0.547974
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 79
| 12.099609
| 40
| 15
| 35.59375
| 355
| 3.599609
| 0.799927
| 1.199951
| 137
| 7.399414
| 146
| 25
| 1,000
| null | 0
|
no(M2 and SIP pres)
| 0
| 621
| 0
|
70.13794
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 10
| null | 0
| 4,685
| 2,963.8652
| 3,459.82812
| null |
white
| 7.699219
| 12
| 0.843994
| 0.655884
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 65
| 12
| 79
| 24
| 36.09375
| 292
| null | 0.5
| 1.399902
| 134
| 7.389648
| 354
| 43
| 1,465
| null | null |
no(M2 and SIP pres)
| 1.722168
| 194
| 1
|
72.90295
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 23,344
| 16,110.2969
| 15,581.7188
| 41.5
|
white
| 26.296875
| 43
| 0.740967
| 0.659912
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 61
| 10.699219
| 140
| 24
| 38.09375
| 87.14062
| null | 0.299988
| 1.099854
| 129
| 7.369141
| 136
| 12
| 3,200
| null | 1
|
SIP>=30
| 1
| 620
| 0
|
53.95798
|
female
| 0
| 28
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 26
| 30,829
| 17,709.4688
| 17,719.1094
| 11.5
|
white
| 27.296875
| 44
| 0.596924
| 0.406982
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 57
| 11.798828
| 88
| 30
| 39
| 182.5
| 3.099609
| 2.399902
| 1.199951
| 137
| 7.509766
| 152
| 15
| 1,424
| null | 6
|
no(M2 and SIP pres)
| 6
| 619
| 0
|
91.90997
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 16
| null | 0
| 13,204
| 8,966.2344
| 11,215.1875
| 16
|
white
| 32.5
| 56
| 0.360962
| 0.168976
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 70
| 0.899902
| 73
| 28
| 35.69531
| null | 2.699707
| 1.299805
| 1.799805
| 135
| null | 239
| 42
| 5,980
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 175
| 1
|
56.31998
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 16
|
under $11k
| 0
| 4,302
| 2,707.6777
| 2,766.57812
| 13
|
white
| 10.699219
| 32
| 0.921997
| 0.866943
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.8
|
no dnr
| 6
| 127
| 12.798828
| 143
| 24
| 36.19531
| 110
| 3.699707
| 2
| 1.399902
| 135
| 7.189453
| 113
| 34
| 900
| null | null |
no(M2 and SIP pres)
| 2.581543
| 618
| 0
|
87.56696
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 9,171
| 6,001.6445
| 5,309.58984
| 7.333332
|
white
| 17.199219
| 24
| 0.821899
| 0.710938
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 121
| 16.597656
| 58
| 32
| 37.89844
| 127.5
| 3.299805
| 0.599976
| 2.799805
| 133
| 7.379883
| 254
| 111
| 765
| null | 2
|
no(M2 and SIP pres)
| 2
| 617
| 0
|
54.13797
|
male
| 1
| 6
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 100
| 13,290
| 9,129.0234
| 9,817.0625
| 40
|
white
| 26.199219
| 29
| 0.250977
| 0.184998
| 1
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 4
| 99
| 0.199982
| 115
| 30
| 39.19531
| null | 3
| null | 1.799805
| 146
| null | 139
| 41
| 2,800
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
60.08499
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
|
>$50k
| 0
| 6,801
| 4,314.7969
| 2,377.79883
| 12
|
white
| 17.296875
| 21
| 0.714966
| 0.434998
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 6
| 101
| 7.199219
| 70
| 22
| 37.29688
| 520
| null | null | 2.199707
| 140
| 7.349609
| 185
| 60
| 2,150
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 80
| 1
|
81.95496
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 22,645
| 15,302.2266
| 16,727.4688
| 42.5
|
white
| 28.699219
| 48
| 0.608887
| 0.50293
| 3
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 5
| 73
| 13.798828
| 61
| 20
| 36.79688
| null | null | null | 1
| 138
| null | 162
| 15
| 2,850
| null | 2
|
<2 mo. follow-up
| 2
| 9
| 1
|
70.94598
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$25-$50k
| 100
| 68,567
| 47,417
| 56,280.75
| 25.75
|
white
| 31.796875
| 68
| 0.081985
| 0.030998
| 9
| 0
| 0
|
no
| null | null |
dnr after sadm
| 24
| 49
| 13.5
| 134
| 10
| 37.89844
| 215
| 3.399902
| 0.299988
| 1.5
| 137
| 7.449219
| 238
| 30
| 1,650
| null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
80.07098
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
>$50k
| 0
| 54,121
| 36,237.0625
| 41,810.0938
| 63
|
white
| 36.09375
| 63
| 0.350952
| 0.234985
| 13
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 120
| 7.299805
| 14
| 10
| 38.89844
| 129
| 3.699707
| 0.699951
| 0.5
| 137
| 7.40918
| 137
| 15
| 3,525
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
61.03799
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 12
| null | 0
| 11,265
| 7,681.9844
| 8,306.57812
| 20.5
|
white
| 21
| 26
| 0.871948
| 0.786987
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 49
| 6.5
| 158
| 10
| 36.79688
| 136
| 2.199707
| 0.599976
| 1.599854
| 131
| 7.429688
| 78
| 12
| 2,875
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 606
| 0
|
82.71899
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
under $11k
| 0
| 33,923
| 21,274.0625
| 23,252.1094
| 25
|
white
| 21.898438
| 36
| 0.775879
| 0.702881
| 1
| 0
| 1
|
no
| 0.8
| 0.8
|
no dnr
| 21
| 83
| 11.199219
| 101
| 28
| 39.09375
| null | null | null | 0.899902
| 138
| null | 130
| 6
| 3,175
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 603
| 0
|
50.00699
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 28,269
| 18,869.2031
| 20,516.5781
| 27
|
white
| 32.796875
| 34
| 0.719971
| 0.633911
| 1
| 0
| 0
|
no
| 0.49
| 0.49
|
no dnr
| 14
| 65
| 19
| 70
| 15
| 36.09375
| 108.15625
| 3.699707
| 0.699951
| 5.399414
| 126
| 7.479492
| 267
| 96
| 190
| null | 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
69.59296
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 2,545
| 1,613.3086
| 1,731.61914
| 13
|
white
| 19.5
| 16
| 0.770996
| 0.523926
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.05
|
dnr after sadm
| 3
| 111
| null | 62
| 16
| 36.39844
| null | null | null | null | 140
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.494751
| 103
| 1
|
74.05096
|
female
| 1
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
under $11k
| 26
| 100,702
| 66,196.125
| 77,436.125
| 40
|
white
| 28.199219
| 31
| 0.455994
| 0.336975
| 4
| 0
| 0
|
yes
| 0.7
| 0.7
|
dnr after sadm
| 47
| 104
| 8.199219
| 79
| 24
| 35.5
| null | 3.899902
| 0.399963
| 0.799927
| 136
| null | 116
| 31
| 2,300
| null | 6
|
<2 mo. follow-up
| 6
| 49
| 1
|
64.58899
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 7,143
| 4,358.4766
| 2,398.69922
| 10
|
white
| 15.798828
| 10
| 0.73291
| 0.462952
| 1
| 0
| 0
|
metastatic
| 1
| 0.51
|
no dnr
| 6
| 108
| 5.799805
| 114
| 16
| 36.19531
| null | null | null | null | 140
| null | null | null | null | null | null | null | 1.982178
| 91
| 1
|
81.41797
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 11,063
| 7,162.5781
| 5,944.11719
| 4.333332
|
white
| 13.5
| 23
| 0.881958
| 0.802979
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 14
| 71
| null | 57
| 20
| 35.89844
| 304.75
| 3.699707
| 1.199951
| 1.699951
| 135
| 7.519531
| 120
| 44
| null | 0
| 0
| null | 0
| 598
| 0
|
88.28699
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
under $11k
| 0
| 20,082
| 13,371.9375
| 15,769.0078
| 44
|
white
| 29.398438
| 49
| 0.593994
| 0.485962
| 1
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 1
| 61
| 3.699707
| 65
| 20
| 36.09375
| null | 4.099609
| 2
| 1.099854
| 132
| null | 176
| 35
| 850
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
65.495
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 15
|
under $11k
| 0
| 5,817
| 3,923.6973
| 3,969.18945
| 5.5
|
white
| 20.398438
| 31
| 0.855957
| 0.762939
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 8
| 64
| 11.298828
| 72
| 14
| 36.09375
| 157.5
| null | null | 1
| 141
| 7.419922
| 354
| 24
| 725
| 2
| 2
|
<2 mo. follow-up
| 2
| 48
| 1
|
69.65399
|
female
| 1
| 11
|
Coma
|
Coma
| 1
| null | null | 61
| 41,832
| 29,165.875
| 32,677.4688
| 27.5
|
white
| 34.898438
| 57
| 0.036995
| 0.017998
| 10
| 1
| 0
|
no
| null | null |
no dnr
| 11
| 77
| 10
| 57
| 28
| 35.79688
| null | 4.299805
| 1.399902
| 1.299805
| 136
| null | 271
| 21
| 1,695
| null | null |
<2 mo. follow-up
| 2.309082
| 11
| 1
|
75.96698
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 44
| 17,883
| 12,190.1406
| 12,751.8594
| 17
|
white
| 18.097656
| 21
| 0.710938
| 0.55188
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 12
| 57
| 11.599609
| 101
| 28
| 36.39844
| 130
| 2.899902
| 0.299988
| 0.799927
| 137
| 7.399414
| 178
| 19
| 1,100
| null | 2
|
no(M2 and SIP pres)
| 2
| 593
| 0
|
69.58795
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 9
|
$11-$25k
| 0
| 4,334
| 2,818.1992
| 3,109.70898
| 10
|
white
| 22.398438
| 14
| 0.571899
| 0.250977
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 6
| 59
| 18.097656
| 96
| 16
| 38.69531
| 127.5
| null | 0.199982
| 1.799805
| 139
| 7.5
| 222
| 36
| 2,631
| null | null | null | 2.578613
| 64
| 1
|
60.51999
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 10
|
$25-$50k
| 44
| 15,369
| 10,618.8906
| 12,286.6797
| 20
|
white
| 31.5
| 89
| 0.319946
| 0.136993
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 4
| 104
| 16.5
| 79
| 28
| 35.89844
| null | 4.699219
| 1.199951
| 1
| 134
| null | 104
| 17
| null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
63.52597
|
male
| 0
| 61
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 44
| 195,557
| 77,800.1875
| 86,105.1875
| 34.75
|
white
| 23.398438
| 39
| 0.560913
| 0.448975
| 5
| 0
| 0
|
yes
| 0.3
| 0.3
|
dnr after sadm
| 15
| 67
| 12.5
| 100
| 20
| 36.09375
| null | 2.199707
| 6.699219
| 1.099854
| 131
| null | 105
| 18
| 1,900
| null | 0
|
no(M2 and SIP pres)
| 0
| 173
| 1
|
87.98596
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 6,883
| 4,599.7266
| 4,546.40625
| 8
|
white
| 18.5
| 27
| 0.695923
| 0.531982
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 10
| 109
| 15.099609
| 104
| 34
| 36.79688
| 309.5
| 3.899902
| 0.599976
| 1.099854
| 132
| 7.489258
| 123
| 13
| null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 590
| 0
|
84.29297
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
|
$25-$50k
| 0
| 18,165
| 11,636.9922
| 12,352.8828
| 12.333328
|
white
| 32
| 57
| 0.546997
| 0.348999
| 1
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 17
| 80
| 9.798828
| 68
| 24
| 38.69531
| 364
| null | 1.299805
| 1.099854
| 137
| 7.489258
| 184
| 26
| 1,775
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 156
| 1
|
63.24399
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| 16,650
| 10,887.9375
| 12,403.4766
| 25
|
white
| 23.5
| 43
| 0.819946
| 0.759888
| 1
| 0
| 0
|
no
| 0.75
| 0.65
|
no dnr
| 12
| 70
| 6.099609
| 73
| 22
| 36.29688
| null | 3.899902
| 0.799927
| 1.099854
| 132
| null | 111
| 14
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 587
| 0
|
67.06097
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 0
| 5,283
| 3,447.1289
| 3,774.14844
| 8.5
|
white
| 6.599609
| 25
| 0.859985
| 0.687988
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.6
|
no dnr
| 8
| 57
| 25
| 120
| 26
| 39.09375
| 237.125
| 2.199707
| 0.799927
| 1.199951
| 138
| 7.399414
| 135
| 19
| 1,815
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 93
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.